The webinar will cover:
1. The introduction of the new UK route to market and the mark of conformity for devices.
2. The transition period for products already CE marked, following confirmation of recognition of the CE mark until 30 June 2023.
3. The implications of Great Britain not implementing the EU Medical Devices Regulation (MDR) and In Vitro Diagnostics Regulation (IVDR).
4. Outline of how the requirements will impact manufacturers in the UK and EU.
Dr Katta will be joined by Gary Slack, Senior Vice President, to discuss BSI’s strategic approach to the new regulation and how we will implement this alongside our EU Notified Body role.
